Previously, our group and others uncovered targeting Cer metabolism enzymes, such as DES1, ACDase, SK1, as wells as certain chain length of Cer could sensitize resistant cells to various therapies and improve HNSCC cell killing [11–15]. The gene discussed is CBLN1; the disease is head and neck squamous cell carcinoma.